Skip to content
Clinical Trials – home

Universitetssykehuset Nord-Norge HF

VerifiedinfoResponsive

Norway Sykehusvegen 38, 9019 Tromsø, Norway

  • 68 trials recruiting
  • Acute myeloid leukaemia · Colitis ulcerative · Crohn's disease
  • Adults and children

About Specializations

Universitetssykehuset Nord-Norge HF in Tromsø, Norway specialises in clinical trials of conditions such as Acute myeloid leukaemia, Colitis ulcerative, Crohn's disease, Chronic kidney disease, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer. The center's work in this field is driven by a commitment to improving patient outcomes through cutting-edge therapies and personalized medicine.

  • Generalized Mantle Cell Lymphoma
  • Metastatic Cancer Disease
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Acute Myeloid Leukemia
  • Gastrointestinal Stromal Tumor
  • High-Risk Medulloblastoma

Through its research, the center is advancing the understanding of cancer biology and developing new therapeutic strategies that are transforming the standard of care for cancer patients worldwide.

Neurology

Specializing in neurology, the center is dedicated to exploring novel treatments for neurological disorders. Its research aims to enhance the quality of life for patients by addressing the complex challenges associated with these conditions.

  • Dementia with Lewy Bodies
  • Multiple Sclerosis
  • Alzheimer's Disease
  • Chronic Migraine

The center's pioneering work in neurology is paving the way for breakthroughs in understanding and treating neurological diseases, offering hope to patients and families affected by these conditions.

Cardiology

In the field of cardiology, the center is leading research efforts to improve cardiovascular health. Its studies focus on innovative therapies and interventions that aim to reduce the burden of heart disease.

  • Coronary Artery Multi-Vessel Disease
  • Acute Coronary Syndrome

By advancing the understanding of cardiovascular conditions, the center is contributing to the development of more effective treatments and preventive measures, ultimately enhancing patient care and outcomes.

Immunology

The center's research in immunology is focused on harnessing the power of the immune system to combat diseases. This includes exploring new immunotherapies and understanding immune responses in various conditions.

  • Rheumatoid Arthritis
  • Polymyalgia Rheumatica
  • Thyroid Eye Disease

Through its innovative research, the center is making significant strides in developing therapies that modulate the immune system, offering new hope for patients with autoimmune and inflammatory diseases.

Gastroenterology

In gastroenterology, the center is committed to advancing the treatment of digestive disorders. Its research focuses on understanding the underlying mechanisms of these conditions and developing targeted therapies.

  • Crohn's Disease
  • Ulcerative Colitis
  • Eosinophilic Esophagitis

The center's work in gastroenterology is leading to new insights and treatment options that improve the lives of patients with chronic digestive diseases.

Endocrinology

Specializing in endocrinology, the center is exploring innovative treatments for hormonal disorders. Its research aims to improve the management and outcomes of these complex conditions.

  • Primary Adrenal Insufficiency
  • Mild Autonomous Cortisol Secretion

Through its research, the center is advancing the understanding of endocrine disorders and developing new therapeutic approaches that enhance patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Sykehusvegen 389019 TromsøNorway
Recruiting now
68 trials
Conditions studied
105
Partner status
Verified

More sites in TromsøNorway

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

124 clinical trials

Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Renal disorder

Recruiting
Investigational
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Scleroderma Research Foundation

Coeliac disease

Recruiting
Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S
Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.